Chemours (CC) PT Lowered to $62 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Chemours (CC) PT Lowered to $68 at BMO Capital
August 6, 2018 8:30 AM EDTBMO Capital lowered its price target on Chemours (NYSE: CC) to $68.00 (from $70.00) while maintaining a Outperform rating.
... MoreChemours (CC) PT Lowered to $47 at UBS
August 3, 2018 8:48 AM EDTUBS lowered its price target on Chemours (NYSE: CC) to $47.00 (from $50.00) while maintaining a Neutral rating.
... MoreChemours (CC) Tops Q2 EPS by 12c
August 2, 2018 4:38 PM EDTChemours (NYSE: CC) reported Q2 EPS of $1.71, $0.12 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.82 billion.
For earnings history and earnings-related data on Chemours (CC) click here.
... More